Credit Suisse Ag Vbi Vaccines Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.38 - $22.5 $43,046 - $2.55 Million	-113,279 Reduced 99.99%	8 $0
Q3 2022 Nov 10, 2022	BUY	$0.73 - $23.4 $746 - $23,914	1,022 Added 0.91%	113,287 $80,000
Q2 2022 Aug 12, 2022	BUY	$0.66 - $1.81 $941 - $2,582	1,427 Added 1.29%	112,265 $90,000
Q1 2022 May 16, 2022	BUY	$1.27 - $2.47 $9,165 - $17,825	7,217 Added 6.96%	110,838 $184,000
Q4 2021 Feb 14, 2022	BUY	$2.21 - $3.22 $6,585 - $9,595	2,980 Added 2.96%	103,621 $241,000
Q3 2021 Nov 12, 2021	BUY	$2.8 - $3.72 $29,993 - $39,848	10,712 Added 11.91%	100,641 $313,000
Q2 2021 Aug 16, 2021	SELL	$2.61 - $4.17 $199,667 - $319,009	-76,501 Reduced 45.97%	89,929 $301,000
Q1 2021 May 14, 2021	SELL	$2.91 - $4.32 $1.28 Million - $1.9 Million	-438,942 Reduced 72.51%	166,430 $518,000
Q4 2020 Feb 12, 2021	SELL	$2.15 - $3.5 $229,366 - $373,387	-106,682 Reduced 14.98%	605,372 $1.67 Million
Q3 2020 Nov 13, 2020	BUY	$2.77 - $6.17 $1.92 Million - $4.27 Million	692,853 Added 3608.42%	712,054 $2.04 Million
Q2 2020 Aug 12, 2020	BUY	$0.87 - $3.13 $16,704 - $60,099	19,201 New	19,201 $60,000
Q1 2020 May 13, 2020	SELL	$0.73 - $1.91 $53,720 - $140,556	-73,590 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$0.48 - $1.38 $25,630 - $73,686	53,396 Added 264.42%	73,590 $102,000
Q3 2019 Nov 12, 2019	BUY	$0.47 - $1.05 $3,398 - $7,592	7,231 Added 55.78%	20,194 $9,000
Q2 2019 Aug 14, 2019	SELL	$0.65 - $2.12 $24,801 - $80,890	-38,156 Reduced 74.64%	12,963 $15,000
Q1 2019 May 14, 2019	BUY	$1.54 - $2.01 $63,323 - $82,649	41,119 Added 411.19%	51,119 $96,000
Q4 2018 Feb 13, 2019	BUY	$1.22 - $2.41 $12,200 - $24,100	10,000 New	10,000 $16,000
Q2 2018 Aug 14, 2018	SELL	$2.75 - $3.85 $44,055 - $61,677	-16,020 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.5 - $4.47 $56,070 - $71,609	16,020 New	16,020 $56,000
Q4 2017 Feb 14, 2018	SELL	$3.29 - $5.03 $48,343 - $73,910	-14,694 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.15 - $4.01 $46,286 - $58,922	14,694	14,694 $57,000

Others Institutions Holding VBIV

# of Institutions

Shares Held

688K

Call Options Held

Put Options Held

Frontier Wealth Management LLC Kansas City, MO

602K
Shares

$12,036
0.01% of portfolio
ETF Managers Group, LLC Summit, NJ

85.7K
Shares

$1,714
0.0% of portfolio

View Full List

About VBI Vaccines Inc

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

More about VBIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account